NCT04770012View on ClinicalTrials.gov

AERIAL Trial: Antiplatelet Therapy in Heart Transplantation

PHASE3RecruitingINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

June 28, 2021

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2029

Conditions
Cardiac Allograft VasculopathyHeart Transplant
Interventions
DRUG

Placebo

patients randomized to placebo study group will be dispensed placebo capsules to be taken daily for the duration of the treatment

DRUG

aspirin

patients randomized to aspirin study group will be dispensed aspirin capsules to be taken daily for the duration of the treatment

DRUG

Clopidogrel

patients randomized to clopidogrel study group will be dispensed clopidogrel capsules to be taken daily for the duration of the treatment

Trial Locations (3)

V6Z 1Y6

RECRUITING

St.Pauls Hospital, Vancouver

K1Y 4W7

RECRUITING

University of Ottawa Heart Institute, Ottawa

M5G 2C4

RECRUITING

Toronto General Hospital UHN, Toronto

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

Ottawa Heart Institute Research Corporation

OTHER

NCT04770012 - AERIAL Trial: Antiplatelet Therapy in Heart Transplantation | Biotech Hunter | Biotech Hunter